NACCO Industries Inc. (NYSE: NC) stock closed at $31.69 on 5/2/24 after a major increase of 15.0%. Moreover, exceptionally high trading volume at 282% of normal accompanied the advance. The stock has risen 10.6% during […]
Monster Beverage Corp (NASDAQ: MNST) has reported earnings for its first fiscal quarter (ending March 31) of $0.42 versus $0.38 for the same period a year ago — an increase of 11%. However, this result […]
Madison Square Garden Sports Cor (NYSE: MSGS) has reported E.P.S. of $1.58 for its third fiscal quarter (ending March 31) versus $2.19 for the same period a year ago — a decline of -28%. For […]
MACOM Technology Solutions Holdi (NASDAQ: MTSI) has reported E.P.S. of $0.21 for its second fiscal quarter (ending March 31) versus $0.36 for the same period a year ago — a decline of -42%. Relative to […]
Live Nation Entertainment Inc (NYSE: LYV) has reported a loss for its first fiscal quarter (ending March 31) of $-0.53 versus a loss $-0.25 for the same period a year ago. E.P.S. were $1.11 for […]
LeMaitre Vascular Inc (NASDAQ: LMAT) has reported E.P.S. of $0.44 for its first fiscal quarter (ending March 31) versus $0.27 for the same period a year ago — an increase of 63%. Relative to the […]
For its first fiscal quarter (ending March 31), Kellogg Co (NYSE: K) has reported a 16% increase in E.P.S. from $0.67 a year ago to $0.78 in the current quarter. Relative to the consensus estimate […]
Iqvia Holdings Inc (NYSE: IQV) has reported E.P.S. of $1.58 for its first fiscal quarter (ending March 31) versus $1.56 for the same period a year ago — an increase of 1%. However, this performance […]
InterDigital Inc (NASDAQ: IDCC) has reported E.P.S. of $3.20 for its first fiscal quarter (ending March 31) versus $3.66 for the same period a year ago — a decline of -13%. However, this performance was […]
DaVita Inc (NYSE: DVA) has reported earnings for its first fiscal quarter (ending March 31) of $2.73 versus $1.28 for the same period a year ago — an increase of 113%. This result exceeded the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research